Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Free to healthcare providers. No ads, no sponsorships, no bias.

Intended for USA healthcare providers only.

Browse Clinical Trial Updates

All
ASCO Updates
Breast Cancer
GI Cancers
GU Cancers
GYN Oncology
Hematological Malignancies
Lung Cancer
Skin Cancer
Dr. Arnab Basu discusses ctDNA as a predictive marker in bladder cancer (Video 1/3)

Dr. Arnab Basu discusses ctDNA as a predictive marker in bladder cancer (Video 1/3)

ctDNA Predictive

Arnab Basu, MD
GU Cancers
Dr. Manali Kamdar describes best practices and impact of timing for CAR-T utilization in patients with LBCL (Video 3/3)

Dr. Manali Kamdar describes best practices and impact of timing for CAR-T utilization in patients with LBCL (Video 3/3)

Best practices

Manali Kamdar, MD
Hematological Malignancies
Dr. Edgardo Santos describes the management of patients receiving SQ amivantamab-based regimens (Video 3/3)

Dr. Edgardo Santos describes the management of patients receiving SQ amivantamab-based regimens (Video 3/3)

Ami Pt Mgmt

Edgardo Santos, MD
Lung Cancer
Dr. Amer Zeidan describes the patient management with luspatercept including RS negative and EPO <200 (Video 3/3)

Dr. Amer Zeidan describes the patient management with luspatercept including RS negative and EPO <200 (Video 3/3)

COMMANDS Outcomes

Amer Zeidan, MD
Hematological Malignancies
Dr. Himisha Beltran describes the safety of PARP inhibitors in treating BRCA2 mutations in prostate cancer (Video 3/3)

Dr. Himisha Beltran describes the safety of PARP inhibitors in treating BRCA2 mutations in prostate cancer (Video 3/3)

PARPi Safety in BRCA2m HSPC

Himisha Beltran, MD
GU Cancers
Dr. Martin Dietrich describes the safety of trastuzumab deruxtecan and practical strategies for managing adverse effects (Video 3/3)

Dr. Martin Dietrich describes the safety of trastuzumab deruxtecan and practical strategies for managing adverse effects (Video 3/3)

Safety of T-Dxd

Martin Dietrich
GI Cancers

Why subscribe?

  • Get one-minute, non-promotional, educational videos from distinguished thought leaders
  • Tailored to topics you select
    • Breast Cancer
    • Lung Cancer
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynecologic Cancers
    • Hemotologic Malignancies
    • Conference updates and more
  • No spam. No ads. No apps to download.
  • Always free and you can opt-out anytime if you feel this isn’t for you.

Fill out the form above to subscribe!

Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Intended for USA healthcare providers only.

If your institution is not listed, please input the Institution / Company name in the field below.

By clicking Subscribe, I agree that I have read and understand IDEOlogy Health’s Privacy Policy and Terms and Conditions and further agree to receive information from IDEOlogy Health and its companies

ideology-health
Privacy Policy
Terms of Service
Inc. 5000

IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.